Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ruxolitinib Enhances Platelet Production in Patients With Thrombocytopenic Myelofibrosis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Feb 2016

Grunwald Michael R, Spivak Jerry L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to Janus Kinase 2
Share to Nitriles
Share to Polycythemia Vera

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Primary Myelofibrosis

Share to Pyrazoles

Share to Pyrimidines

Share to Thrombocytopenia

Source

Identifiers

PMID: 24958831
DOI: 10.1200/JCO.2013.51.0057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ruxolitinib Enhances Platelet Production in Patients With Thrombocytopenic Myelofibrosis.PMID 24958831Read ↗

Practical management of myelofibrosis with ruxolitinib.Semantic proximity Read ↗

Efficacy of ruxolitinib for myelofibrosis.Semantic proximity Read ↗

Recombinant human thrombopoietin: basic biology and evaluation of clinical studiesSemantic proximity Read ↗

Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopeniaSemantic proximity Read ↗

Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosis.Semantic proximity Read ↗

Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for PharmacistsSemantic proximity Read ↗

Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients.Semantic proximity Read ↗

Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.Semantic proximity Read ↗

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.Semantic proximity Read ↗

Thrombopoietin receptor agonists in hereditary thrombocytopenias.Semantic proximity Read ↗

Ruxolitinib (RUX) in combination with 5-Azacytidine (AZA) as therapy for patients with myelofibrosis (MF)Semantic proximity Read ↗

Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.